Clinical Trial Update: Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docetaxel in older patients with metastatic breast cancer, lung cancer, or prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Lung Cancer | Phase 2 | Status: COMPLETED